Size Of Drug Discounts In Part D Employer-Sponsored Plans At Stake In Debate Over CMS Proposal
Executive Summary
The biopharmaceutical industry is fighting a CMS proposal that would impact the size of manufacturer discounts on drugs provided in the Medicare Part D coverage gap in an emerging type of Part D coverage for retirees – employer-sponsored group waiver plans, known as EGWPs.